Literature DB >> 17724662

The fenton activity of iron(III) in the presence of deferiprone.

Lakshmi D Devanur1, Hendrik Neubert, Robert C Hider.   

Abstract

Hydroxyl radical production from a range of clinically relevant iron chelators in the presence of hydrogen peroxide was measured using the deoxyribose oxidation assay. Hydroxyl radical production from an iron complex is dependent on whether the ligand is able to completely surround the iron, thereby preventing access of reductants to the coordinated iron cation. The partially coordinated [(deferiprone)(2)Fe(III)](+) complex is able to generate hydroxyl radicals in the presence of oxidants, whereas the fully coordinated [(deferiprone)(3)Fe(III)](0) complex is not. Hydroxyl radical production from iron(III)deferiprone complexes is dependent on the molar ratio of iron to deferiprone, which, in turn, affects the speciation of the complex. Mass spectrometry data have confirmed the presence of the [(deferiprone)(2)Fe(III)](+) complex in aqueous solution. Hydroxyl radical production from the [(deferiprone)(2)Fe(III)](+) complex is maximal in the presence of equimolar ascorbate and hydrogen peroxide and is abolished in the absence of hydrogen peroxide. Under biological conditions, any [(deferiprone)(2)Fe(III)](+) complex formed intracellularly will be rapidly reduced by ascorbate. The resulting unstable iron(II) complex will dissociate to hexa-aquo iron(II), a major component of the endogenous intracellular labile iron pool. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17724662     DOI: 10.1002/jps.21039

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics.

Authors:  Li Ma; Yongjun Gao; Anthony W Maresso
Journal:  J Bacteriol       Date:  2015-09-21       Impact factor: 3.490

2.  Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone.

Authors:  V A Timoshnikov; T Kobzeva; O Y Selyutina; N E Polyakov; G J Kontoghiorghes
Journal:  J Biol Inorg Chem       Date:  2019-03-13       Impact factor: 3.358

3.  Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity.

Authors:  Roger Gumbau-Brisa; M Trisha C Ang; Bruce E Holbein; Matthias Bierenstiel
Journal:  Biometals       Date:  2020-10-19       Impact factor: 2.949

4.  A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.

Authors:  Olivier Reelfs; Vincenzo Abbate; Robert C Hider; Charareh Pourzand
Journal:  J Invest Dermatol       Date:  2016-04-22       Impact factor: 8.551

5.  Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.

Authors:  Maciej W Garbowski; Patricia Evans; Evangelia Vlachodimitropoulou; Robert Hider; John B Porter
Journal:  Haematologica       Date:  2017-06-22       Impact factor: 9.941

6.  Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis.

Authors:  Jaswinder Singh Maras; Sukanta Das; Sachin Sharma; Sukriti Sukriti; Jitendra Kumar; Ashish Kumar Vyas; Dhananjay Kumar; Adil Bhat; Gaurav Yadav; Manish Chandra Choudhary; Shvetank Sharma; Guresh Kumar; Chhagan Bihari; Nirupma Trehanpati; Rakhi Maiwall; Shiv Kumar Sarin
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

7.  What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19?

Authors:  Barry B Muhoberac
Journal:  Front Cell Infect Microbiol       Date:  2020-12-14       Impact factor: 5.293

8.  Using substantial reductant concentration with chelation therapy to enhance small aggregate dispersal, iron mobilization, and its clearance in neurodegenerative diseases.

Authors:  Barry B Muhoberac
Journal:  Front Neurosci       Date:  2022-09-15       Impact factor: 5.152

9.  The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.

Authors:  Zhu-Ling Guo; Des R Richardson; Danuta S Kalinowski; Zaklina Kovacevic; Kian Cheng Tan-Un; Godfrey Chi-Fung Chan
Journal:  J Hematol Oncol       Date:  2016-09-27       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.